JPS5484017A - Producing of human antii cancer senstizing lymphocyte - Google Patents

Producing of human antii cancer senstizing lymphocyte

Info

Publication number
JPS5484017A
JPS5484017A JP15148677A JP15148677A JPS5484017A JP S5484017 A JPS5484017 A JP S5484017A JP 15148677 A JP15148677 A JP 15148677A JP 15148677 A JP15148677 A JP 15148677A JP S5484017 A JPS5484017 A JP S5484017A
Authority
JP
Japan
Prior art keywords
senstizing
antii
lymphocyte
cancer
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15148677A
Other languages
Japanese (ja)
Inventor
Kazuhide Satou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GAN MENEKI SHINKOU ZAIDAN
Original Assignee
GAN MENEKI SHINKOU ZAIDAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GAN MENEKI SHINKOU ZAIDAN filed Critical GAN MENEKI SHINKOU ZAIDAN
Priority to JP15148677A priority Critical patent/JPS5484017A/en
Priority to GB7847387A priority patent/GB2010089A/en
Priority to FR7835235A priority patent/FR2414918A1/en
Publication of JPS5484017A publication Critical patent/JPS5484017A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP15148677A 1977-12-16 1977-12-16 Producing of human antii cancer senstizing lymphocyte Pending JPS5484017A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP15148677A JPS5484017A (en) 1977-12-16 1977-12-16 Producing of human antii cancer senstizing lymphocyte
GB7847387A GB2010089A (en) 1977-12-16 1978-12-06 Immunotherapeutic agent for treating cancer
FR7835235A FR2414918A1 (en) 1977-12-16 1978-12-14 PROCESS FOR THE IN VITRO PREPARATION OF AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCER

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15148677A JPS5484017A (en) 1977-12-16 1977-12-16 Producing of human antii cancer senstizing lymphocyte

Publications (1)

Publication Number Publication Date
JPS5484017A true JPS5484017A (en) 1979-07-04

Family

ID=15519544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15148677A Pending JPS5484017A (en) 1977-12-16 1977-12-16 Producing of human antii cancer senstizing lymphocyte

Country Status (3)

Country Link
JP (1) JPS5484017A (en)
FR (1) FR2414918A1 (en)
GB (1) GB2010089A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802277A1 (en) * 1978-01-19 1979-08-02 Jaeger Karl Heinz Dr Med METHOD FOR PRODUCING AN IMMUNOLOGICAL ACTIVE SUBSTANCE COMPLEX FROM CELLS AGAINST BOUGIC GROWTH
EP0147689B1 (en) * 1983-12-05 1990-09-19 Asahi Kasei Kogyo Kabushiki Kaisha A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
US5308626A (en) * 1985-06-28 1994-05-03 Toni N. Mariani Lymphokine activated effector cells for antibody-dependent cellular cytotoxicity (ADCC) treatment of cancer and other diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617886A1 (en) * 1967-03-06 1971-01-28 Dr Med Karl Theurer Process for the preparation of drugs with selective tropism against cancer and certain organs

Also Published As

Publication number Publication date
FR2414918A1 (en) 1979-08-17
GB2010089A (en) 1979-06-27

Similar Documents

Publication Publication Date Title
GB2002378B (en) Preparation of oligo-imides
JPS5492972A (en) Manufacture of nucleoside
JPS5392780A (en) Method of producing 33methylpyridine
JPS53135969A (en) Method of producing cycloenamide
JPS5484017A (en) Producing of human antii cancer senstizing lymphocyte
JPS5460387A (en) Preparation of polyisobuthene
JPS53130491A (en) Synthesis of nnacyll llthreonine
SU678864A1 (en) Method of producing hexafluoride- and pentafluoridechlorbenzoles
IL52021A (en) Preparation of , -di-n-propyl-acetonitrile
GB2009698B (en) Preparation of emulsions
GB2003140B (en) Method of producing n-formylamine
YU186077A (en) Method of producing human albumen
JPS53117444A (en) Method of producing
JPS53110161A (en) Method of producing metallmade vacuummbottle
JPS5444048A (en) Continuous productction of tempra
IL52238A0 (en) Preparation of alpha-ketocarboxamides
JPS5456280A (en) Method of producing skin replica
JPS53141276A (en) Method of producing vintlpyridines
JPS53110162A (en) Method of producing metallmade vacuummbottle
JPS5391450A (en) Method of producing metallmade vacuummbottle
AU4069178A (en) Preparation of 6-thiatetracycline
IE781843L (en) Preparation of morpholinodithiothiazoles
JPS53120965A (en) Method of producing wadding
GB2007651B (en) Preparation of diacetoxybutene
JPS53119460A (en) Method of producing metallmade vacuummbottle